March 2017 Volume 40, Number 3
In This Issue
289
In This Issue of Diabetes Care
Pathophysiology/Complications
367
Perspectives in Care
291
P.-J. Saulnier, E. Gand, G. Velho, K. Mohammedi, P. Zaoui, M. Fraty,
J.M. Halimi, R. Roussel, S. Ragot, and S. Hadjadj, for the
SURDIAGENE Study Group
Basal Glucose Can Be Controlled, but the Prandial Problem
PersistsdIt’s the Next Target!
M.C. Riddle
Clinical Care/Education/Nutrition/Psychosocial Research
301
309
375
Pancreatic Effects of Liraglutide or Sitagliptin in Overweight
Patients With Type 2 Diabetes: A 12-Week Randomized,
Placebo-Controlled Trial
M.M. Smits, L. Tonneijck, M.H.A. Muskiet, M.H.H. Kramer,
I.C. Pieters-van den Bos, K.E.W. Vendrik, T. Hoekstra, M.J. Bruno,
M. Diamant, D.H. van Raalte, and D.L. Cahen
Longitudinal Trajectories of Metabolic Control From
Childhood to Young Adulthood in Type 1 Diabetes From
a Large German/Austrian Registry: A Group-Based Modeling
Approach
Health Care Transition Preparation and Experiences in a U.S.
National Sample of Young Adults With Type 1 Diabetes
383
391
332
Glyburide Versus Metformin and Their Combination for the
Treatment of Gestational Diabetes Mellitus: A Randomized
Controlled Study
398
Cardiovascular and Metabolic Risk
405
A.K. Wright, E. Kontopantelis, R. Emsley, I. Buchan, N. Sattar,
M.K. Rutter, and D.M. Ashcroft
346
352
412
Emerging Technologies and Therapeutics
Predictive Hyperglycemia and Hypoglycemia Minimization:
In-Home Evaluation of Safety, Feasibility, and Efficacy in
Overnight Glucose Control in Type 1 Diabetes
T. Spaic, M. Driscoll, D. Raghinaru, B.A. Buckingham, D.M. Wilson,
P. Clinton, H.P. Chase, D.M. Maahs, G.P. Forlenza, E. Jost, I. Hramiak,
T. Paul, B.W. Bequette, F. Cameron, R.W. Beck, C. Kollman,
J.W. Lum, and T.T. Ly, for the In-Home Closed-Loop (IHCL)
Study Group
Diabetic Retinopathy: A Position Statement by the American
Diabetes Association
S.D. Solomon, E. Chew, E.J. Duh, L. Sobrin, J.K. Sun, B.L. VanderBeek,
C.C. Wykoff, and T.W. Gardner
Review
419
Type 2 Diabetes and Comorbid Symptoms of Depression and
Anxiety: Longitudinal Associations With Mortality Risk
K. Naicker, J.A. Johnson, J.C. Skogen, D. Manuel, S. Øverland,
B. Sivertsen, and I. Colman
359
Position Statement
Serum Levels of Apolipoproteins and Incident Type 2
Diabetes: A Prospective Cohort Study
A. Brahimaj, S. Ligthart, M.A. Ikram, A. Hofman, O.H. Franco,
E.J.G. Sijbrands, M. Kavousi, and A. Dehghan
Association of Cardiovascular Risk Factors and Myocardial
Fibrosis With Early Cardiac Dysfunction in Type 1 Diabetes:
The Diabetes Control and Complications Trial/Epidemiology
of Diabetes Interventions and Complications Study
A.C. Armstrong, B. Ambale-Venkatesh, E. Turkbey, S. Donekal,
E. Chamera, J.-Y. Backlund, P. Cleary, J. Lachin, D.A. Bluemke,
and J.A.C. Lima, for the DCCT/EDIC Research Group
Epidemiology/Health Services Research
Life Expectancy and Cause-Specific Mortality in Type 2
Diabetes: A Population-Based Cohort Study Quantifying
Relationships in Ethnic Subgroups
First Infant Formula Type and Risk of Islet Autoimmunity in
The Environmental Determinants of Diabetes in the Young
(TEDDY) Study
S. Hummel, A. Beyerlein, R. Tamura, U. Uusitalo,
C. Andrén Aronsson, J. Yang, A. Riikonen, Å. Lernmark,
M.J. Rewers, W.A. Hagopian, J.-X. She, O.G. Simell, J. Toppari,
A.-G. Ziegler, B. Akolkar, J.P. Krischer, S.M. Virtanen, J.M. Norris,
and the TEDDY Study Group
Z. Nachum, N. Zafran, R. Salim, N. Hissin, J. Hasanein,
Y. Gam Ze Letova, A. Suleiman, and E. Yefet
338
Systems Biology–Derived Biomarkers to Predict Progression
of Renal Function Decline in Type 2 Diabetes
G. Mayer, H.J.L. Heerspink, C. Aschauer, A. Heinzel, G. Heinze,
A. Kainz, J. Sunzenauer, P. Perco, D. de Zeeuw, P. Rossing,
M. Pena, and R. Oberbauer, for the SYSKID Consortium
Combination Therapy With Exenatide Plus Pioglitazone Versus
Basal/Bolus Insulin in Patients With Poorly Controlled Type 2
Diabetes on Sulfonylurea Plus Metformin: The Qatar Study
M. Abdul-Ghani, O. Migahid, A. Megahed, J. Adams, C. Triplitt,
R.A. DeFronzo, M. Zirie, and A. Jayyousi
Circulating Modified Metabolites and a Risk of ESRD in
Patients With Type 1 Diabetes and Chronic Kidney Disease
M.A. Niewczas, A.V. Mathew, S. Croall, J. Byun, M. Major,
V.S. Sabisetti, A. Smiles, J.V. Bonventre, S. Pennathur,
and A.S. Krolewski
K.C. Garvey, N.C. Foster, S. Agarwal, L.A. DiMeglio, B.J. Anderson,
S.D. Corathers, M.E. Desimone, I.M. Libman, S.K. Lyons,
A.L. Peters, J.K. Raymond, and L.M. Laffel
325
Novel Protein Glycan–Derived Markers of Systemic
Inflammation and C-Reactive Protein in Relation to
Glycemia, Insulin Resistance, and Insulin Secretion
C. Lorenzo, A. Festa, A.J. Hanley, M.J. Rewers, A. Escalante,
and S.M. Haffner
A. Schwandt, J.M. Hermann, J. Rosenbauer, C. Boettcher,
D. Dunstheimer, J. Grulich-Henn, O. Kuss, B. Rami-Merhar,
C. Vogel, and R.W. Holl, on behalf of the DPV Initiative
317
Association of Circulating Biomarkers (Adrenomedullin,
TNFR1, and NT-proBNP) With Renal Function Decline in
Patients With Type 2 Diabetes: A French Prospective Cohort
Management of Nonalcoholic Fatty Liver Disease in Patients
With Type 2 Diabetes: A Call to Action
F. Bril and K. Cusi
Issues and Events
431
Issues and Events
e-Letters – Observations
e27
Risk of Myopathy Associated With DPP-4 Inhibitors in
Combination With Statins: A Disproportionality Analysis
Using Data From the WHO and French Spontaneous
Reporting Databases
V. Labat, M. Arnaud, G. Miremont-Salamé, F. Salvo, B. Bégaud,
and A. Pariente
Keep up with the latest information for Diabetes Care and other ADA titles
via Facebook (/ADAJournals) and Twitter (@ADA_Journals).
Icons shown below appear on the first page of an article if more
information is available online.
All articles in Diabetes Care are available online at diabetes.org/diabetescare.
Cover articles ( ) and select content are available free of charge. Other
articles are available free to print subscribers or can be purchased as e-prints
or reprints.
ADA’s Diabetes Core Update podcasts are available at diabetesjournals.org and
through iTunes.
e30
Association Between Diabetes, Level of Glycemic Control,
and Eye Infection: A Cohort Study
A.S. Ansari, S. de Lusignan, B. Arrowsmith, W. Hinton, N. Munro,
and A. McGovern
e32
e36
The Virtual Office Visit for Women With Gestational
Diabetes Mellitus
D.A. Sacks, D. Ling Grant, M. Macias, X. Li, and J.M. Lawrence
Comment on Hofer et al. International Comparison of
Smoking and Metabolic Control in Patients With Type 1
Diabetes. Diabetes Care 2016;39:e177–e178
B. Balkau, S. Soulimane, D. Simon, and W.H. Herman
Higher Parathyroid Hormone Level Is Associated With
Increased Arterial Stiffness in Type 1 Diabetes
E.H. Zobel, S. Theilade, B.J. von Scholten, F. Persson, L. Tarnow,
M. Lajer, T.W. Hansen, and P. Rossing
e34
e-Letters – Comments and Responses
e37
Response to Comment on Hofer et al. International
Comparison of Smoking and Metabolic Control in Patients
With Type 1 Diabetes. Diabetes Care 2016;39:e177–e178
S.E. Hofer, K. Miller, J.M. Hermann, D.J. DeSalvo, M. Riedl,
I.B. Hirsch, W. Karges, R.W. Beck, R.W. Holl, and D.M. Maahs, for
the DPV Initiative and the T1D Exchange Clinic Network
The American Diabetes Association (ADA) is the nation’s leading voluntary
health organization supporting diabetes research, information, and advocacy. Its
mission is to prevent and cure diabetes and to improve the lives of all people
affected by diabetes. ADA is the leading publisher of comprehensive diabetes
information. Its huge library of books and periodicals covers every aspect of
diabetes and diabetes care.
To join ADA: Call 1-800-806-7801 or visit professional.diabetes.org/membership
To subscribe to ADA journals: Call 1-800-DIABETES or go to diabetesjournals
.org
To order ADA books: Call 1-800-232-6733 or visit shopdiabetes.org
To access ADA’s library of professional resources: Go to professional
.diabetes.org
For more information about diabetes or ADA programs and services:
Call 1-800-DIABETES. E-mail: [email protected] or visit diabetes.org
To locate an ADA/NCQA Recognized Provider of quality diabetes care in
your area: Visit recognition.ncqa.org
To join the fight to increase funding for diabetes research, end
discrimination, and improve insurance coverage: Call 1-800-DIABETES or
visit diabetes.org/advocacy
To find out how you can get involved with the programs in your
community: Call 1-800-DIABETES or visit diabetes.org/in-my-community
To find out about important research regarding diabetes: Go to diabetes
.org/research-and-practice
To make a donation or memorial contribution: Call 1-800-DIABETES or visit
diabetes.org/donate
Cover: Hiking in the Red Rock Doodle. Credit: dddb. For more information, please visit gettyimages.com.